0001209191-21-024664.txt : 20210402 0001209191-21-024664.hdr.sgml : 20210402 20210402170029 ACCESSION NUMBER: 0001209191-21-024664 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210402 DATE AS OF CHANGE: 20210402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weiser Jorg CENTRAL INDEX KEY: 0001797782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 21802683 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-01 0 0001490978 Schrodinger, Inc. SDGR 0001797782 Weiser Jorg C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 0 1 0 0 EVP & Managing Director Common Stock 2021-04-01 4 M 0 418 4.34 A 117470 D Common Stock 2021-04-01 4 S 0 418 78.34 D 117052 D Common Stock 17390 I BY ANTERIO CONSULT AND RESEARCH GMBH Stock Option (right to buy) 4.34 2021-04-01 4 M 0 418 0.00 D 2028-11-29 Common Stock 418 9196 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2020 The shares are beneficially owned by Anterio Consult & Research GmbH ("Anterio"). Dr. Weiser is a shareholder and former managing director of Anterio and disclaims beneficial ownership of the shares held by Anterio, except to the extent of his pecuniary interest therein, if any. This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022. /s/ Donald Shum, as attorney-in-fact for Jorg Weiser 2021-04-02